Home > > > > Report Detail

Global Regenerative Medicine Partnering 2012-2018: Deal trends, players, financials and forecasts

Publisher Name :
Date: 01-Oct-2018
No. of pages: 717
Inquire Before Buying

The Global Regenerative Medicine Partnering 2010-2018: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the regenerative medicine including cell therapy, organ regeneration, stem cells and tissue regeneration partnering deals and agreements entered into by the worlds leading healthcare companies.

The Global Regenerative Medicine Partnering 2010-2018: Deal trends, players, financials and forecasts report provides comprehensive understanding and unprecedented access to the regenerative medicine including cell therapy, organ regeneration, stem cells and tissue regeneration partnering deals and agreements entered into by the worlds leading healthcare companies.

Trends in regenerative medicine

Deal terms analysis

Partnering agreement structure

Partnering contract documents

Top deals by value

Most active dealmakers

Average deal terms for regenerative medicine and stem cells

The report provides a detailed understanding and analysis of how and why companies enter Regenerative Medicine partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and proceed to commercialization of outcomes.

This report provides details of the latest Regenerative Medicine agreements announced in the life sciences since 2010.

The report takes the reader through a comprehensive review Regenerative Medicine deal trends, key players, top deal values, as well as deal financials, allowing the understanding of how, why and under what terms, companies are entering Regenerative Medicine partnering deals.

The report presents financial deal term values for Regenerative Medicine deals, listing by headline value, upfront payments, milestone payments and royalties, enabling readers to analyse and benchmark the financial value of deals.

The middle section of the report explores the leading dealmakers in the Regenerative Medicine partnering field; both the leading deal values and most active Regenerative Medicine dealmaker companies are reported allowing the reader to see who is succeeding in this dynamic dealmaking market.

One of the key highlights of the report is that over 950 online deal records of actual Regenerative Medicine deals, as disclosed by the deal parties, are included towards the end of the report in a directory format - by company A-Z, stage of development, deal type, therapy focus, and technology type - that is easy to reference. Each deal record in the report links via Weblink to an online version of the deal.

In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Whilst many companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases and databases do not.

The initial chapters of this report provide an orientation of Regenerative Medicine dealmaking. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in Regenerative Medicine dealmaking since 2010, including details of headline, upfront, milestone and royalty terms.

Chapter 3 provides a review of the leading Regenerative Medicine deals since 2010. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract.

Chapter 4 provides a comprehensive listing of the top 25 most active companies in Regenerative Medicine dealmaking with a brief summary followed by a comprehensive listing of Regenerative Medicine deals announded by that company, as well as contract documents, where available.

Chapter 5 provides a comprehensive and detailed review of Regenerative Medicine partnering deals signed and announced since Jan 2010, where a contract document is available in the public domain. Each deal title links via Weblink to an online version of the deal record and contract document, providing easy access to each contract document on demand.

Chapter 6 provides a comprehensive and detailed review of Regenerative Medicine partnering deals signed and announced since Jan 2010. The chapter is organized by specific Regenerative Medicine technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

A comprehensive series of appendices is provided organized by Regenerative Medicine partnering company A-Z, stage of development, deal type, and therapy focus. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each deal on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Regenerative Medicine partnering and dealmaking since 2010.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Regenerative Medicine technologies and products.

Key benefits

Global Regenerative Medicine Partnering 2010-2018: Deal trends, players, financials and forecasts provides the reader with the following key benefits:

In-depth understanding of Regenerative Medicine deal trends since 2010

Access to headline, upfront, milestone and royalty data

Analysis of the structure of Regenerative Medicine agreements with numerous real life case studies

Detailed access to actual Regenerative Medicine contracts entered into by leading biopharma companies

Identify most active Regenerative Medicine dealmakers since 2010

Insight into terms included in a Regenerative Medicine partnering agreement, with real world examples

Understand the key deal terms companies have agreed in previous deals

Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Report scope

Global Regenerative Medicine Partnering 2010-2018: Deal trends, players, financials and forecasts is intended to provide the reader with an in-depth understanding and access to Regenerative Medicine trends and structure of deals entered into by leading companies worldwide.

Regenerative Medicine Partnering Terms and Agreements includes:

Trends in Regenerative Medicine dealmaking in the biopharma industry since 2010

Analysis of Regenerative Medicine deal structure

Access to headline, upfront, milestone and royalty data

Case studies of real-life Regenerative Medicine deals

Access to Regenerative Medicine contract documents

Leading Regenerative Medicine deals by value since 2010

Most active Regenerative Medicine dealmakers since 2010

In Global Regenerative Medicine Partnering 2010-2018: Deal trends, players, financials and forecasts, the available deals are listed by:

Company A-Z

Headline value

Stage of development at signing

Deal component type

Specific therapy target

Technology type

Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The Global Regenerative Medicine Partnering 2010-2018: Deal trends, players, financials and forecasts report provides comprehensive access to available deals and contract documents for over 950 Regenerative Medicine deals.

Analyzing actual contract agreements allows assessment of the following:

What are the precise rights granted or optioned?

What is actually granted by the agreement to the partner company?

What exclusivity is granted?

What is the payment structure for the deal?

How aresalesand payments audited?

What is the deal term?

How are the key terms of the agreement defined?

How are IPRs handled and owned?

Who is responsible for commercialization?

Who is responsible for development, supply, and manufacture?

How is confidentiality and publication managed?

How are disputes to be resolved?

Under what conditions can the deal be terminated?

What happens when there is a change of ownership?

What sublicensing and subcontracting provisions have been agreed?

Which boilerplate clauses does the company insist upon?

Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?

Which jurisdiction does the company insist upon for agreement law?

Global Regenerative Medicine Partnering 2012-2018: Deal trends, players, financials and forecasts

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Regenerative Medicine dealmaking
2.1. Introduction
2.2. Regenerative Medicine partnering over the years
2.3. Most active Regenerative Medicine dealmakers
2.4. Regenerative Medicine partnering by deal type
2.5. Regenerative Medicine partnering by therapy area
2.6. Deal terms for Regenerative Medicine partnering
2.6.1 Regenerative Medicine partnering headline values
2.6.2 Regenerative Medicine deal upfront payments7
2.6.3 Regenerative Medicine deal milestone payments
2.6.4 Regenerative Medicine royalty rates

Chapter 3 - Leading Regenerative Medicine deals
3.1. Introduction
3.2. Top Regenerative Medicine deals by value

Chapter 4 - Most active Regenerative Medicine dealmakers
4.1. Introduction
4.2. Most active Regenerative Medicine dealmakers
4.3. Most active Regenerative Medicine partnering company profiles

Chapter 5 - Regenerative Medicine contracts dealmaking directory
5.1. Introduction
5.2. Regenerative Medicine contracts dealmaking directory

Chapter 6 - Regenerative Medicine dealmaking by technology type

Chapter 7 - Partnering resource center
7.1. Online partnering
7.2. Partnering events
7.3. Further reading on dealmaking

Appendices
Appendix 1 - Regenerative Medicine deals by company A-Z
Appendix 2 - Regenerative Medicine deals by stage of development
Discovery
Preclinical
Phase I
Phase II
Phase III
Regulatory
Marketed
Formulation
Appendix 3 - Regenerative Medicine deals by deal type
Asset purchase
Assignment
Bigpharma outlicensing
Co-development
Collaborative R&D
Co-market
Co-promotion
CRADA
Cross-licensing
Development
Distribution
Equity purchase
Evaluation
Grant
Joint venture
Licensing
Litigation
Manufacturing
Marketing
Material transfer
Option
Promotion
Research
Settlement
Spin out
Sub-license
Supply
Technology transfer
Termination
Warranty
Appendix 4 - Regenerative Medicine deals by therapy area
Appendix 5 -Deal type definitions
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from Current Partnering

List of Tables and Figures

Figure 1: Regenerative Medicine partnering since 2010
Figure 2: Active Regenerative Medicine dealmaking activity- 2010 to 2018
Figure 3: Regenerative Medicine partnering by deal type since 2010
Figure 4: Regenerative Medicine partnering by disease type since 2010
Figure 5: Regenerative Medicine deals with a headline value
Figure 6: Regenerative Medicine deals with an upfront value
Figure 7: Regenerative Medicine deals with a milestone value
Figure 8: Regenerative Medicine deals with a royalty rate value
Figure 9: Top Regenerative Medicine deals by value since 2010
Figure 10: Most active Regenerative Medicine dealmakers 2010 to 2018
Figure 11: Online partnering resources
Figure 12: Forthcoming partnering events
  • Global Tissue Engineered Skin Substitutes Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global Tissue Engineered Skin Substitutes market was valued at US$ 1571.8 million in 2023 and is anticipated to reach US$ 3109.6 million by 2030, witnessing a CAGR of 9.8% during The forecast period 2024-2030. North American market for Tissue Engineered Skin Substitutes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Tissue Engineered Skin Substitutes is est......
  • Global Tissue Engineering Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 134
    According to our LPI (LP Information) latest study, the global Tissue Engineering market size was valued at US$ 26430 million in 2023. With growing demand in downstream market, the Tissue Engineering is forecast to a readjusted size of US$ 90330 million by 2030 with a CAGR of 19.2% during review period. The research report highlights the growth potential of the global Tissue Engineering market. Tissue Engineering are expected to show stable growth in the future market. However, product d......
  • Global Regenerative Medicine Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 150
    According to our LPI (LP Information) latest study, the global Regenerative Medicine market size was valued at US$ 32640 million in 2023. With growing demand in downstream market, the Regenerative Medicine is forecast to a readjusted size of US$ 116410 million by 2030 with a CAGR of 19.9% during review period. The research report highlights the growth potential of the global Regenerative Medicine market. Regenerative Medicine are expected to show stable growth in the future market. Howev......
  • Global Tissue Engineered Skin Substitutes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 28-Dec-2023        Price: US 3380 Onwards        Pages: 108
    Market Overview of Global Tissue Engineered Skin Substitutes market: According to our latest research, the global Tissue Engineered Skin Substitutes market looks promising in the next 5 years. As of 2022, the global Tissue Engineered Skin Substitutes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Tissue-engineered skin substitutes have become viable as a suitable alternative to auto- ......
  • Regenerative Medicine Products - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 121
    The global Regenerative Medicine Products market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Regenerative Medicine Products in various end use industries. The expanding demands from the Dermatology, Cardiovascular, CNS and Orthopedic, are propelling Regenerative Medicine Products market. Cell Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ ......
  • Tissue Engineered Skin Substitutes - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 96
    The global Tissue Engineered Skin Substitutes market size is expected to reach US$ 3109.6 million by 2029, growing at a CAGR of 9.8% from 2023 to 2029. The market is mainly driven by the significant applications of Tissue Engineered Skin Substitutes in various end use industries. The expanding demands from the Burn Injury, Diabetic, Vascular Ulcer and Others, are propelling Tissue Engineered Skin Substitutes market. Acellular, one of the segments analysed in this report, is projected to record %......
  • Global Tissue Engineering and Regeneration Market Research Report 2023
    Published: 21-Nov-2023        Price: US 2900 Onwards        Pages: 98
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Tissue Engineering and Regeneration market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Advanced Cell Technology - Ocata Therapeutics - Arteriocyte - Therapeutics - BioTissue Technologies - Kinetic Concepts - Bi......
  • Global Tissue Analysis Products Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 09-Nov-2023        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Tissue Analysis Products market: According to our latest research, the global Tissue Analysis Products market looks promising in the next 5 years. As of 2022, the global Tissue Analysis Products market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global......
  • Regenerative Medicine Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 950
    Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the regenerative medicine deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of regenerative medicine deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter regenerative medicine deals. These deals tend to be multicomponent, s......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs